{"version":"1.0","type":"link","title":"[Treatment with interferon α-1b, interleukin-2, and thalidomide for persistent RUNX1::RUNX1T1 in a patient with KIT-mutated acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review].","author_name":"Mi RH 외","author_url":"https://prs-insight.online/author/Mi%20RH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166276","thumbnail_width":1200,"thumbnail_height":630}